Mabs | www.gmachineinfo.com | 全球机械文献资源网

OA期刊

ISSN	1942-0862
刊名	Mabs
出版商	Taylor & Francis Inc.
url	https://www.tandfonline.com/loi/kmab20
机构	Taylor & Francis Ltd.

全部

2010	2011	2012	2013	2014	2015
2016	2017	2018	2019	2020	2021
2022	2023	2024	2025

2016, vol.8, no.1	2016, vol.8, no.2	2016, vol.8, no.3	2016, vol.8, no.4	2016, vol.8, no.5	2016, vol.8, no.6
2016, vol.8, no.7	2016, vol.8, no.8

题名

作者

出版年

年卷期

Characterization of alanine to valine sequence variants in the Fc region of nivolumab biosimilar produced in Chinese hamster ovary cells

Yantao Li;Tuo Fu;Tao Liu;Huaizu Guo;Qingcheng Guo;Jin Xu;Dapeng Zhang;Weizhu Qian;Jianxin Dai;Bohua Li;Yajun Guo;Sheng Hou;Hao Wang;

2016

2016, vol.8, no.5

Mitigation of reversible self-association and viscosity in a human IgG1 monoclonal antibody by rational, structure-guided Fv engineering

James C. Geoghegan;Ryan Fleming;Melissa Damschroder;Steven M. Bishop;Hasige A. Sathish;Reza Esfandiary;

2016

2016, vol.8, no.5

Characterization of mAb dimers reveals predominant dimer forms common in therapeutic mAbs

Friederike Plath;Philippe Ringler;Alexandra Graff-Meyer;Henning Stahlberg;Matthias E. Lauer;Arne C. Rufer;Melissa A. Graewert;Dmitri Svergun;Gerald Gellermann;Christof Finkler;Jan O. Stracke;Atanas Koulov;Volker Schnaible;

2016

2016, vol.8, no.5

A novel antibody discovery platform identifies anti-influenza A broadly neutralizing antibodies from human memory B cells

Xiaodong Xiao;Yan Chen;Reena Varkey;Nicole Kallewaard;Adem C. Koksal;Qing Zhu;Herren Wu;Partha S. Chowdhury;William F. Dall'Acqua;

2016

2016, vol.8, no.5

Modeling bispecific monoclonal antibody interaction with two cell membrane targets indicates the importance of surface diffusion

Bram G. Sengers;Sean McGinty;Fatma Z. Nouri;Maryam Argungu;Emma Hawkins;Aymen Hadji;Andrew Weber;Adam Taylor;Armin Sepp;

2016

2016, vol.8, no.5

Simultaneous blockade of VEGF and Dll4 by HD105, a bispecific antibody, inhibits tumor progression and angiogenesis

Dongheon Lee;Dongin Kim;Yu Bin Choi;Kyungjae Kang;Eun-Sil Sung;Jin-Hyung Ahn;Junseo Goo;Dong-Hoon Yeom;Hyun Sook Jang;Kyung Duk Moon;Sang Hoon Lee;Weon-Kyoo You;

2016

2016, vol.8, no.5

An optimized antibody-single-chain TRAIL fusion protein for cancer therapy

Martin Siegemund;Oliver Seifert;Maria Zarani;Tamara Džinić;Valentino De Leo;Doris Göttsch;Sabine Münkel;Meike Hutt;Klaus Pfizenmaier;Roland E. Kontermann;

2016

2016, vol.8, no.5

Evaluating imbalances of adverse events during biosimilar development

Alicia M. Vana;Amy W. Freyman;Steven D. Reich;Donghua Yin;Ruifeng Li;Scott Anderson;Ira A. Jacobs;Charles M. Zacharchuk;Reginald Ewesuedo;

2016

2016, vol.8, no.5

Serum pharmacokinetics and cerebrospinal fluid concentration analysis of the new IgG4 monoclonal antibody GNbAC1 to treat multiple sclerosis: A Phase 1 study

François Curtin;Virginie Vidal;Corinne Bernard;Arno Kromminga;Alois B. Lang;Hervé Porchet;

2016

2016, vol.8, no.5

Tissue expression profile of human neonatal Fc receptor (FcRn) in Tg32 transgenic mice

Yao-Yun Fan;Lindsay B. Avery;Mengmeng Wang;Denise M. O'Hara;Sheldon Leung;Hendrik Neubert;

2016

2016, vol.8, no.5